Masaaki Matsushima1, Ken Sakushima1, Yasuhiro Kanatani2, Naoki Nishimoto3, Jun Sawada4, Takeshi Matsuoka5, Haruo Uesugi6, Naoya Minami7, Kazuya Sako8, Asako Takei9, Shin Hisahara10, Akiko Tamakoshi11, Norihiro Sato3, Hidenao Sasaki1,12, Ichiro Yabe1, Department of Health and Welfare, Hokkaido Government13, Sapporo City Public Health Office14, HoRC-MSA study group15
(1.Department of Neurology, Hokkaido University, Japan, 2.Department of Clinical Pharmacology, Tokai University School of Medicine, Japan, 3.Hokkaido University Hospital Clinical Research and Medical Innovation Center, Japan, 4.Cardiovascular, Respiratory and Neurology Division, Department of Internal Medicine, Asahikawa Medical University, Japan, 5.Department of Neurology, Date Red Cross Hospital, Japan, 6.Aizen Hospital, Japan, 7.Department of Neurology, Hokkaido Medical Center, Japan, 8.Department of Neurology, Nakamura Memorial Hospital, Japan, 9.Hokkaido Neurological Hospital, Japan, 10.Department of Neurology, Sapporo Medical University School of Medicine, Japan, 11.Department of Public Health, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan, 12.Hakodate Central General Hospital, Japan, 13.Department of Health and Welfare, Hokkaido Government, Japan, 14.Sapporo City Public Health Office, Japan, 15.HoRC-MSA study group, Japan)
Abstract password authentication.
You can find the password on page 15 of the program book.